Comparison of IVF and ICSI in Human IVF

NCT ID: NCT03513913

Last Updated: 2018-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-30

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this prospective randomized clinical trial we plan to compare two fertilization method which are widely used during in vitro fertilization (IVF) treatment. Outcome of conventional IVF and intracytoplasmic sperm injection (ICSI) treatment will be compared in this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IVF

Oocytes fertilized by conventional in vitro fertilization (IVF) method

Group Type EXPERIMENTAL

ICSI

Intervention Type PROCEDURE

Oocytes are fertilized by conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI)

ICSI

Oocytes fertilized by intracytoplasmic sperm injection (ICSI) method

Group Type EXPERIMENTAL

ICSI

Intervention Type PROCEDURE

Oocytes are fertilized by conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ICSI

Oocytes are fertilized by conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Infertile patients entering in vitro fertilization treatment At least 1 oocytes collected Semen sample is suitable for IVF and ICSI fertilization as well Number of oocytes collected is lower than 5 AND/OR female age is equal or more than 40 years

Exclusion Criteria

Samen sample is not suitable for conventional IVF fertilization Previous conventional IVF treatment resulted in \<50% fertilization rate
Minimum Eligible Age

18 Years

Maximum Eligible Age

48 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Semmelweis University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter Fancsovits, Ph.D.

Senior cilincal embryologyst

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Fancsovits, PhD

Role: STUDY_CHAIR

Semmelweis University First Department of Obstetrics and Gynecology, Budapest, Hungary

Janos Urbancsek, DSc

Role: PRINCIPAL_INVESTIGATOR

Semmelweis University First Department of Obstetrics and Gynecology, Budapest, Hungary

Csaba Pribenszky, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Veterinary Science, Budapest, Hungary

Adam Lehner, PhD

Role: PRINCIPAL_INVESTIGATOR

Semmelweis University First Department of Obstetrics and Gynecology, Budapest, Hungary

Zita Kaszás, BSc

Role: PRINCIPAL_INVESTIGATOR

Semmelweis University First Department of Obstetrics and Gynecology, Budapest, Hungary

Miklós I Ács, MD

Role: PRINCIPAL_INVESTIGATOR

Klinikum Kempten Oberallgäu, Kempten, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Semmelweis University First Department of Obstetrics and Gynecology

Budapest, , Hungary

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Peter Fancsovits, PhD

Role: CONTACT

+36208250520

Janos Urbancsek, DSc

Role: CONTACT

+3612660115

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Peter Fancsovits, Ph.D.

Role: primary

+36309821382

Janos Urbancsek, DSc

Role: backup

+3612660115

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SemmelweisU-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fresh Vs Frozen Surgical Sperm in IVF
NCT03361982 TERMINATED NA
Use of IMSI in Poor Responders to IVF
NCT02358733 TERMINATED NA